Abstract
The rsk of hemorrhagic complications for patients undergoing anticoagulated dermatologic operation is a controversial issue. Among 5 recent studies,1-5 4 of which were controlled, no increased risk of perioperative bleeding complications was found with the continued administration of anticoagulants and platelet inhibitors in patients who underwent cutaneous operation procedures. These studies concluded that the preoperative discontinuation of blood thinners is not necessary. Potential disadvantages of discontinuing blood thinners before operation include an increased risk of thromboembolic complications,6-9 and additional inconvenience and cost for the patient, who must often have laboratory tests monitored and coordinate extra visits with the primary care physician or cardiologist.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
